We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Design Therapeutics (DSGN) announced the appointment of Chris Storgard, M.D., as Chief Medical Officer. Most recently, Dr. Storgard served as ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price.

19:50 EDT Kazia Therapeutics (KZIA) trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

Would TREM2 agonism change this picture? To test this, the scientists treated mice with 4D9:ATV. Developed by Denali Therapeutics, this TREM2 agonist antibody is equipped with an antibody transport ...

Denali Therapeutics, Neurogene, Larimar Therapeutics, and Grace Science will be the first companies to benefit from the FDA's higher levels of guidance and advice in areas like clinical trial ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in ...

MANCHESTER, England, April 17, 2025 /PRNewswire/ -- Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system ...

Tvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in Times Square.

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is supported by rising IBD prevalence and ongoing geographic ...